Prospective New 1st Line T2D Treatment
    May 23, 2019

    Prospective New 1st Line T2D Treatment

    We spoke with Andrew Reaume, Ph.D., MBA, President and CEO, and Ramana Kuchibhatla, Ph.D., VP of Clinical Development at Melior…
    Could Early Intensive Insulin Therapy be a Breakthrough T2D Treatment?
    May 22, 2019

    Could Early Intensive Insulin Therapy be a Breakthrough T2D Treatment?

    I have long been frustrated that ADA Guidelines still have insulin therapy as the last step in its Diabetes Standards…
    Using AI to Find High-Risk Patients for T2 Diabetes Could Save Billions and Extend Lives
    May 15, 2019

    Using AI to Find High-Risk Patients for T2 Diabetes Could Save Billions and Extend Lives

    We spoke with Chaitanya Mamillapalli, MD, MRCP, FAPCR, Endocrinologist (bio) with the Springfield Clinic a 400 physician multi-specialty organization with…
    Is Zero Card the Future of Better Care?
    May 9, 2019

    Is Zero Card the Future of Better Care?

    We spoke with Stanley N. Schwartz, MD, FACP, and Chief Medical Officer of Zero Card — https://www.thezerocard.com/ — about why…
    New Effective Drug for Kids and Teens with T2D
    May 2, 2019

    New Effective Drug for Kids and Teens with T2D

    We spoke with William Tamborlane, MD, (bio) Professor of Pediatrics (Endocrinology); Chief, Pediatric Endocrinology at Yale School of Medicine about…
    The Biggest Diabetes Coaching Firm You Don’t Know
    April 30, 2019

    The Biggest Diabetes Coaching Firm You Don’t Know

    We spoke with David Weingard, CEO of Cecelia Health — www.ceceliahealth.com. This New York-based firm employs CDEs to coach people…

    Latest News